A detailed history of Cable Hill Partners, LLC transactions in Sanofi stock. As of the latest transaction made, Cable Hill Partners, LLC holds 8,669 shares of SNY stock, worth $419,146. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,669
Previous 8,494 2.06%
Holding current value
$419,146
Previous $412,000 21.12%
% of portfolio
0.05%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$48.54 - $58.53 $8,494 - $10,242
175 Added 2.06%
8,669 $499,000
Q2 2024

Jul 22, 2024

BUY
$45.39 - $50.36 $385,542 - $427,757
8,494 New
8,494 $412,000
Q3 2023

Oct 27, 2023

BUY
$50.95 - $55.2 $55,688 - $60,333
1,093 Added 24.75%
5,510 $295,000
Q2 2023

Jul 19, 2023

BUY
$50.45 - $57.18 $3,581 - $4,059
71 Added 1.63%
4,417 $238,000
Q1 2023

May 04, 2023

SELL
$45.86 - $54.45 $114,191 - $135,580
-2,490 Reduced 36.42%
4,346 $236,000
Q4 2022

Feb 06, 2023

BUY
$38.86 - $48.55 $29,572 - $36,946
761 Added 12.53%
6,836 $331,000
Q3 2022

Nov 14, 2022

SELL
$37.22 - $100.5 $6,290 - $16,984
-169 Reduced 2.71%
6,075 $231,000
Q2 2022

Aug 11, 2022

BUY
$48.99 - $57.46 $305,893 - $358,780
6,244 New
6,244 $312,000
Q2 2019

Aug 06, 2019

SELL
$40.43 - $44.3 $213,349 - $233,771
-5,277 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$40.83 - $45.43 $50,220 - $55,878
-1,230 Reduced 18.9%
5,277 $234,000
Q4 2018

Feb 12, 2019

BUY
$41.48 - $45.59 $260,204 - $285,986
6,273 Added 2680.77%
6,507 $282,000
Q3 2018

Nov 14, 2018

SELL
$40.0 - $44.84 $3,000 - $3,363
-75 Reduced 24.27%
234 $10,000
Q1 2018

Apr 20, 2018

SELL
$38.98 - $45.76 $150,073 - $176,176
-3,850 Reduced 92.57%
309 $12,000
Q4 2017

Feb 22, 2018

SELL
$42.86 - $50.61 $17,958 - $21,205
-419 Reduced 9.15%
4,159 $183,000
Q3 2017

Oct 27, 2017

BUY
$47.04 - $50.34 $215,349 - $230,456
4,578
4,578 $228,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.